5 Prostate Cancer Clinical Trials in Fayetteville, NC (2026)

Q: How do I join a clinical trial in Fayetteville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you.

Recruiting Prostate Cancer Studies in Fayetteville

NCT07028853Recruiting

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

This study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide alone in participants with mCSPC who ar...

Fayetteville, NC1,000 participantsPfizer

View Study Details

NCT06629779Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC who are ARSi or abirat...

Fayetteville, NC900 participantsPfizer

View Study Details

NCT06470243Recruiting

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that keeps growing even when t...

Fayetteville, NC528 participantsSWOG Cancer Research Network

View Study Details

NCT05939414Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after defini...

Fayetteville, NC450 participantsNovartis Pharmaceuticals

View Study Details

NCT07181161Recruiting

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer....

Fayetteville, NC177 participantsAstraZeneca

View Study Details

About Prostate Cancer Clinical Trials in Fayetteville

Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.

There are currently 5 prostate cancer clinical trials recruiting participants in Fayetteville, NC. These studies are seeking a combined 3,055 participants. Research is being sponsored by Pfizer, SWOG Cancer Research Network, Novartis Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prostate Cancer Clinical Trials in Fayetteville — FAQ

Are there prostate cancer clinical trials in Fayetteville?

Yes, there are 5 prostate cancer clinical trials currently recruiting in Fayetteville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fayetteville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fayetteville research site will contact you about next steps.

Are clinical trials in Fayetteville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fayetteville studies also compensate for your time and travel.

What prostate cancer treatments are being tested?

The 5 active trials in Fayetteville are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.

Data updated July 13, 2026 from ClinicalTrials.gov